Fortress Biotech Current Ratio 2010-2021 | FBIO

Fortress Biotech current ratio from 2010 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Fortress Biotech Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.32B $0.07B 4.54
2021-03-31 $0.32B $0.05B 5.91
2020-12-31 $0.27B $0.05B 5.14
2020-09-30 $0.24B $0.04B 6.38
2020-06-30 $0.20B $0.06B 3.51
2020-03-31 $0.16B $0.05B 3.07
2019-12-31 $0.16B $0.05B 3.43
2019-09-30 $0.17B $0.05B 3.55
2019-06-30 $0.16B $0.04B 4.49
2019-03-31 $0.14B $0.05B 2.79
2018-12-31 $0.11B $0.06B 2.00
2018-09-30 $0.16B $0.07B 2.25
2018-06-30 $0.17B $0.06B 2.76
2018-03-31 $0.20B $0.08B 2.52
2017-12-31 $0.18B $0.07B 2.56
2017-09-30 $0.18B $0.07B 2.69
2017-06-30 $0.19B $0.05B 3.56
2017-03-31 $0.15B $0.05B 2.88
2016-12-31 $0.11B $0.06B 1.94
2016-09-30 $0.10B $0.04B 2.55
2016-06-30 $0.08B $0.01B 5.34
2016-03-31 $0.08B $0.01B 7.78
2015-12-31 $0.10B $0.01B 9.45
2015-09-30 $0.07B $0.01B 7.88
2015-06-30 $0.06B $0.01B 12.42
2015-03-31 $0.07B $0.01B 11.74
2014-12-31 $0.07B $0.00B 17.28
2014-09-30 $0.07B $0.00B 20.26
2014-06-30 $0.08B $0.00B 22.25
2014-03-31 $0.08B $0.00B 18.57
2013-12-31 $0.10B $0.01B 8.92
2013-09-30 $0.11B $0.01B 11.05
2013-06-30 $0.07B $0.01B 7.61
2013-03-31 $0.05B $0.01B 7.31
2012-12-31 $0.04B $0.01B 7.91
2012-09-30 $0.05B $0.00B 10.75
2012-06-30 $0.04B $0.00B 9.81
2012-03-31 $0.02B $0.00B 4.70
2011-12-31 $0.02B $0.00B 6.69
2011-09-30 $0.03B $0.00B 7.26
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-12-31 $0.02B $0.00B 9.62
2010-09-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.338B $0.046B
Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71